Trial Outcomes & Findings for OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits (NCT NCT01875783)

NCT ID: NCT01875783

Last Updated: 2017-12-22

Results Overview

Percentage of participants who are referred to a retina specialist for evaluation and management of DME after OCT imaging and OCT-guided referral algorithm

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

385 participants

Primary outcome timeframe

Baseline visit

Results posted on

2017-12-22

Participant Flow

Participant milestones

Participant milestones
Measure
OCT Imaging
All study participants will undergo optical coherence tomography imaging and will be referred to a retina specialist for further standard care evaluation and management if they are identified as having diabetic macular edema or the scan quality is not sufficient to evaluate macular status. OCT imaging: Optical coherence tomography (OCT) imaging is a noninvasive, rapid, and readily performed method for evaluating the anatomy of the central retina.
Overall Study
STARTED
385
Overall Study
COMPLETED
385
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
OCT Imaging
n=385 Participants
All study participants will undergo optical coherence tomography imaging and will be referred to a retina specialist for further standard care evaluation and management if they are identified as having diabetic macular edema or the scan quality is not sufficient to evaluate macular status. OCT imaging: Optical coherence tomography (OCT) imaging is a noninvasive, rapid, and readily performed method for evaluating the anatomy of the central retina.
Age, Categorical
<=18 years
0 Participants
n=93 Participants
Age, Categorical
Between 18 and 65 years
294 Participants
n=93 Participants
Age, Categorical
>=65 years
91 Participants
n=93 Participants
Age, Continuous
54.8 years
STANDARD_DEVIATION 14.1 • n=93 Participants
Sex: Female, Male
Female
193 Participants
n=93 Participants
Sex: Female, Male
Male
192 Participants
n=93 Participants
Region of Enrollment
United States
385 Participants
n=93 Participants

PRIMARY outcome

Timeframe: Baseline visit

Percentage of participants who are referred to a retina specialist for evaluation and management of DME after OCT imaging and OCT-guided referral algorithm

Outcome measures

Outcome measures
Measure
Retina Specialist Care
n=385 Participants
Percentage of participants who follow-up with a retina specialist for evaluation and management of DME after OCT imaging and OCT-guided referral algorithm as compared with the percentage of patients currently receiving retina eye care (assessed by study participant self-report as well as by determination of historical retina eye care rates from documentation in the medical records of study-eligible patients seen within the previous 6 months)
Rates of Retina Care Referral for Patients With Diabetic Macular Edema
44 Participants

SECONDARY outcome

Timeframe: Baseline visit

Count of eyes that are referred to a retina specialist for evaluation and management of DME after OCT imaging and OCT-guided referral algorithm

Outcome measures

Outcome measures
Measure
Retina Specialist Care
n=761 eyes
Percentage of participants who follow-up with a retina specialist for evaluation and management of DME after OCT imaging and OCT-guided referral algorithm as compared with the percentage of patients currently receiving retina eye care (assessed by study participant self-report as well as by determination of historical retina eye care rates from documentation in the medical records of study-eligible patients seen within the previous 6 months)
Retinal Referral Rates for Patients With DME
59 eyes

SECONDARY outcome

Timeframe: One month

Population: This is the subgroup of participants who were referred for retinal care by the OCT guided referral algorithm

Percentage of participants are referred by OCT-guided algorithm who are confirmed to have vision threatening retinopathy at first visit with retina specialist after study enrollment

Outcome measures

Outcome measures
Measure
Retina Specialist Care
n=34 Participants
Percentage of participants who follow-up with a retina specialist for evaluation and management of DME after OCT imaging and OCT-guided referral algorithm as compared with the percentage of patients currently receiving retina eye care (assessed by study participant self-report as well as by determination of historical retina eye care rates from documentation in the medical records of study-eligible patients seen within the previous 6 months)
Rates of Retinal Treatment for Patients With DME
14 Participants

SECONDARY outcome

Timeframe: 9 months

Population: This is the subgroup of participants who were referred for retina care by the OCT guided referral algorithm.

Percentage of participants who are referred by OCT guided algorithm to a retina specialist who receive treatment for DME over the course of 9 months follow-up by retina specialist

Outcome measures

Outcome measures
Measure
Retina Specialist Care
n=34 Participants
Percentage of participants who follow-up with a retina specialist for evaluation and management of DME after OCT imaging and OCT-guided referral algorithm as compared with the percentage of patients currently receiving retina eye care (assessed by study participant self-report as well as by determination of historical retina eye care rates from documentation in the medical records of study-eligible patients seen within the previous 6 months)
Rates of Retinal Treatment Over 1 Year for Patients With DME
18 Participants

Adverse Events

OCT Imaging

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Jennifer Sun

Joslin Diabetes Center

Phone: 617-209-2554

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place